We have a new group of Emerging Leaders in Mucosal Immunology for early 2025! We’ll be showcasing reviews and thoughts from rising researchers . First up Eduardo Villablanca Ejv at Karolinska Institutet in Stockholm, Sweden.

IL-6 mediates defense against #influenza virus by promoting protective antibody responses but not innate inflammation mucosalimmunology.org/article/S1933-…

Tolebrutinib is more effective in reducing the risk of disability progression in MS patients with paramagnetic rim lesions, per an analysis. bit.ly/43kzLvp #news

People with MS who eat more fish are significantly less likely to experience confirmed disability progression, a new study in Sweden finds. bit.ly/43w6rCa #news

growkudos.com/publications/1…

Our Pathbreaking Findings under mentorship of Ashutosh Mangalam published in @PNAS journal #Congratulation #TeamWork #DreamWork #GutMicrobiota #MultipleSclerosis

It’s mucosal Monday!! Have you listened to episode 2, if not please do on your favorite platform. Also don’t forget to listen to medical mystery puzzle and send in your answers!! #mucosalimmunologypodcast #medicalmysteries

Comparison of human macrophages derived from peripheral blood and bone marrow The Journal of Immunology doi.org/10.1093/jimmun…

42-Parameter (40-Color) Spectral Flow Cytometry Panel for Comprehensive Immunophenotyping of Human Peripheral Blood Leukocytes doi.org/10.1002/cyto.a…

Glimpses of Jan Suraaj Overseas members celebrating Holi around the world

Myeloid derived suppressor cells transferred to the lungs improved survival of mice during Pseudomonas aeruginosa infection suggesting potential prophylactic and therapeutic roles: mucosalimmunology.org/article/S1933-…

While patients who switched to the therapy later saw significant improvements, those who received it as a first-line treatment tended to have even greater benefits. bit.ly/4iyEHBV #MS #MultipleSclerosis #MSResearch #MSNews #MSTreatment

Great lab outing with our ever-growing MS group! From Karandikar to Karandikar-Mangalam (2015) to Karandikar-Mangalam-Boyden after Alex’s tenure-track promotion—who knows what’s next? Thanks Nitin Nitin Karandikar for fostering this thriving community! #LabFamily #GrowingTogether

ButovskyLab The immune checkpoint TIM-3 is targeted for cancer therapy, & we found that it is also a promising therapeutic target for Alzheimer's disease. Very excited to share this study led by Kimitoshi Kimura, Ayshwarya Subramanian @Zhuoran_Yin1 & Ahad Khalilnezhad Gene Lay Institute of Immunology & Inflammation. Now out nature 2/2

Fascinating Finding From Kuchroo Lab. Many Congratulation

Bariatric surgery causes long term changes to our gut microbiome— Maggie Bohm, Liza Makowski Lab & team UTHSC Center for Cancer Research now show these changes can improve the body’s immune response to current breast cancer treatments. See more: insight.jci.org/articles/view/…

Great work--congrats to Blaise Kimmel, PhD (now at The James at Ohio State) and thanks for letting us (Kimryn Rathmell and the R^2 lab) participate!

Enrollment is now complete in two Phase 3 clinical trials testing vidofludimus calcium in adults with relapsing forms of multiple sclerosis. multiplesclerosisnewstoday.com/news-posts/202… #MultipleSclerosis #MSTreatment #MSResearch #MSNews

New advanced imaging technology that detects specific molecules in the brain may find signs of MS lesions months earlier, a study shows. buff.ly/YB5RcwG #MultipleSclerosis #MSTreatment #MSResearch #MSNews

Great breakfast meeting with our Grand Rounds speaker, Professor Booki Min, a leading immunologist and an inspiring scientist. His seminar on how LAG3 regulates T regulatory cell (Treg) function in autoimmunity and cancer was phenomenal. #ShahiLab #UIowa Booki Min